Bridgebio Pharma Inc $79.86 (-1.35, 1.69%)

NASDAQ
95% success, from Analysis 1* of this Model (*Public)
Summary
SHORTSELL: Best moves 22 which gains 1165.01, return on capital invested 8.76%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action